Effect Of Glycopyrrolate On Lung Function, Health Status And Dyspnea In Age Subgroups: A Pooled Analysis From The Gem1 And Gem2 Studies

被引：0
|
作者：
Mahler, D. A. [1 ]
Kerwin, E. [2 ]
Gifford, A. H. [1 ]
Yadao, A. [3 ]
D'Andrea, P. [3 ]
Uddin, A. [3 ]
Bray, B. Franke [4 ]
机构：
[1] Geisel Sch Med Dartmouth, Hanover, NH USA
[2] Clin Res Inst Southern Oregon, Medford, OR USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Pharma AG, Basel, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
AIR-FLOW LIMITATION; COPD PATIENTS;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6775
引用
收藏
页数：2
相关论文
共 36 条
  • [21] QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE Studies
    Chapman, Kenneth R.
    Bateman, Eric D.
    Chen, Hungta
    Hu, Hulin
    Fogel, Robert
    Banerji, Donald
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2015, 2 (01): : 48 - 60
  • [22] Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies
    Raal, Frederick J.
    Tuomilehto, Jaakko
    Sposito, Andrei C.
    Fonseca, Francisco A.
    Averna, Maurizio
    Farnier, Michel
    Santos, Raul D.
    Ferdinand, Keith C.
    Wright, R. Scott
    Navarese, Eliano Pio
    Lerch, Danielle M.
    Louie, Michael J.
    Lee, L. Veronica
    Letierce, Alexia
    Robinson, Jennifer G.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (05) : 735 - 743
  • [23] Improvement In Lung Function With Indacaterol/glycopyrrolate (ind/gly) In Patients With Moderate To Severe COPD From The Us: A Subgroup Analysis From The Flight1 And Flight2 Studies
    Kerwin, E.
    Mahler, D. A.
    FowlerTaylor, A.
    Maitra, S.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [24] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
    Sharma, S.
    Goodin, T.
    Bowling, A.
    Price, B.
    Ozol-Godfrey, A.
    Sanjar, S.
    Ohar, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] Effect of Metabolic Syndrome Status on Lung Function and Patient- reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Indacaterol/Glycopyrrolate: Co-morbidity Analysis of the Phase 3 FLIGHT1 and 2 Studies
    Carlin, Brian
    Ferguson, Gary T.
    Sanjar, Shahin
    Sharma, Sanjay
    Ozol-Godfrey, Ayca
    Goodin, Thomas
    CIRCULATION, 2018, 138
  • [26] Once-Daily Qva149 Improves Lung Function And Health Status In COPD Treatment Naive Patients: A Pooled Analysis Of Arise, Enlighten, Shine And Spark Studies
    Wedzicha, J.
    D'Urzo, A. D.
    D'Andrea, P.
    Mezzi, K.
    Chen, H.
    Fogel, R.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] QVA149 Demonstrated Significant Improvement in Lung Function Compared With Placebo and Its Monocomponents: Pooled Analysis From the FLIGHT1 and FLIGHT2 Studies
    Kerwin, Edward
    Ayers, Tim
    FowlerTaylor, Angel
    Patalano, Francesco
    Banerji, Donald
    Maitra, Samopriyo
    CHEST, 2015, 148 (04)
  • [28] Dual Bronchodilation With QVA149 Improves Dyspnea in Patients With Moderate-to-Severe COPD: Pooled Analysis From the FLIGHT1 and FLIGHT2 Studies
    Mahler, Donald
    Larbig, Michael
    Patalano, Francesco
    Maitra, Samopriyo
    Banerji, Donald
    CHEST, 2015, 148 (04)
  • [29] Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies
    Donohue, J. F.
    Kerwin, E. M.
    Fuale, S.
    Yadao, A.
    Thach, C.
    Taylor, A. Fowler
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [30] Indacaterol/glycopyrrolate Significantly Improves COPD Assessment Test (cat) Scores In Us Patients With Moderate-To-Severe COPD: Subgroup Analysis From Pooled Flight1 And Flight2 Studies
    Fogel, R.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
1234